The “What I Wish I Knew” series of articles is a service of AAPP’s Resident and New Practitioner Committee. Articles are intended to provide advice from experts for students, residents, and new practitioners. Articles are not intended to provide in-depth disease state or pharmacotherapy information nor replace any peer-reviewed educational materials.
Searching for Solutions
The “What I Wish I Knew” series of articles is a service of AAPP’s Resident and New Practitioner Committee. Articles are intended to provide advice from experts for students, residents, and new practitioners. Articles are not intended to provide in-depth disease state or pharmacotherapy information nor replace any peer-reviewed educational materials.
The “What I Wish I Knew” series of articles is a service of AAPP’s Resident and New Practitioner Committee. Articles are intended to provide advice from experts for students, residents, and new practitioners. Articles are not intended to provide in-depth disease state or pharmacotherapy information nor replace any peer-reviewed educational materials.
The “What I Wish I Knew” series of articles is a service of AAPP’s Resident and New Practitioner Committee. Articles are intended to provide advice from experts for students, residents, and new practitioners. Articles are not intended to provide in-depth disease state or pharmacotherapy information nor replace any peer-reviewed educational materials.
The “What I Wish I Knew” series of articles is a service of AAPP’s Resident and New Practitioner Committee. Articles are intended to provide advice from experts for students, residents, and new practitioners. Articles are not intended to provide in-depth disease state or pharmacotherapy information nor replace any peer-reviewed educational materials.
What you need to know about medication adherence...
What you need to know about medication adherence...
What you need to know about medication adherence...
What you need to know about medication adherence...
What you need to know about medication adherence...
What you need to know about medication adherence...
What you need to know about medication adherence...
What you need to know about metabolic side effects of psychiatric medications...
Medication-induced sexual dysfunction occurs when there is a problem that leads to frustration with sexual activity or performance.
What you need to know about psychiatric medications...
What you need to know about e-cigarettes...
What You Need to Know About Off-Label Usage of Medication...
What is a LAI? What are LAIs used for? Learn this and what else you need to know...
What you need to know about generic medications...
Antiepileptics and/or mood stabilizers are the cornerstones of bipolar disorder management. They each contain a unique set of monitoring parameters, including therapeutic drug monitoring. Patient-specific factors, such as mood state, organ function, and pregnancy status, may help guide clinicians on selecting the appropriate mood stabilizer.
Antipsychotics are associated with adverse effects. Clinicians should adhere to conscious monitoring of the adverse effects related to use with antipsychotics. Experts have formulated recommendations regarding monitoring parameters to assist with prevention, early detection, and management of potential adverse effects.
Antipsychotics are used in the management of schizophrenia and other psychiatric disorders. Several major trials have been conducted examining the treatment of schizophrenia, including examining effectiveness, side effect profile, and pharmacoeconomic differences. These major trials help guide the way that antipsychotics are utilized.
Management of pain in patients with comorbid substance use disorders can be challenging. Providers may be hesitant to use opioid analgesics in patients with a history of substance misuse or those currently receiving substance use disorder treatment. However, these patients may still experience pain and should have their pain adequately treated.
Antipsychotic dose equivalents may be utilized when switching between antipsychotics or when comparing different medications. Multiple methods are used to calculate antipsychotic dose equivalences, each with their own strengths and limitations. Variation in receptor binding profiles of newer agents, changes to methodology in clinical trials over the decades, and lack of dose response data for older agents means no one method will apply to all available agents.
Changes in cytochrome P450 (CYP) enzyme metabolism are a common cause of drug-drug interactions. Several psychotropic agents are significantly impacted by CYP interactions or cause interactions by inhibiting or inducing CYP metabolism. Is there a list of CYP substrates and interacting medications?1-4